Isosakuranetin

Isosakuranetin is a citrus-derived flavanone compound that inhibits TRPM3 calcium channels with an IC50 of approximately 1 μM in cellular models. This bioactive compound modulates inflammatory pathways including NF-κB and MAPK/ERK signaling cascades.

Origin & History

Isosakuranetin is an O-methylated flavanone flavonoid (C16H14O5) naturally occurring in citrus species, particularly sweet orange (Citrus sinensis) and bergamot (Citrus bergamia), where it serves as a biomarker for fruit consumption. It is typically extracted from fruit peels using solvent-based methods or chromatographic isolation, yielding a white powder with poor water solubility.

Historical & Cultural Context

No direct historical use of isolated isosakuranetin exists in traditional medicine. It occurs naturally in Citrus bergamia (bergamot), used in Italian folk medicine since the 18th century for digestive purposes, and in sweet orange peels used in European herbalism.

Health Benefits

• TRPM3 channel inhibition for potential pain management (IC50 ~1 μM in cellular models, PMID: 28258192) - preliminary evidence only
• Anti-inflammatory effects through modulation of NF-κB and MAPK/ERK pathways - demonstrated in vitro only
• Oxidative stress reduction via PI3K/Akt/mTOR pathway modulation - limited to cellular studies
• Potential immune modulation through calcium influx inhibition - preclinical evidence only
• Possible metabolic effects similar to related citrus flavonoids - extrapolated from naringenin studies, no direct evidence

How It Works

Isosakuranetin functions as a selective TRPM3 channel antagonist, blocking calcium influx with an IC50 of ~1 μM in vitro. The compound suppresses inflammatory responses by inhibiting NF-κB nuclear translocation and downregulating MAPK/ERK phosphorylation cascades. Additionally, it activates PI3K/Akt/mTOR signaling to enhance cellular antioxidant defenses and reduce oxidative stress markers.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses exist for isosakuranetin. Research is limited to preclinical studies, including a 2017 study demonstrating TRPM3 channel blockade in cellular models (PMID: 28258192), with rodent studies using 10-50 mg/kg for anti-inflammatory effects.

Clinical Summary

Current research on isosakuranetin is limited to preclinical in vitro studies using cell culture models. TRPM3 channel inhibition studies demonstrated IC50 values around 1 μM in laboratory conditions, but no human clinical trials have been conducted. Anti-inflammatory effects have been observed only in isolated cell systems with no dosage optimization or bioavailability data. The absence of human studies means therapeutic efficacy, optimal dosing, and clinical safety profiles remain unestablished.

Nutritional Profile

Isosakuranetin (4'-methoxy-5,7-dihydroxyflavanone, C₁₆H₁₄O₅, MW 286.28) is a methylated flavanone found naturally in blood oranges (Citrus sinensis, ~0.5–2 mg/kg fresh weight), grapefruit peel, and certain citrus juices, as well as in the rhizome of Alpinia katsumadai. It is the 4'-O-methyl ether of naringenin. As a secondary plant metabolite, it has no significant macronutrient, vitamin, or mineral content. Typical dietary intake from citrus sources is very low (<1–5 mg/day). Bioavailability is limited due to extensive Phase II metabolism (glucuronidation and sulfation in the intestine and liver); oral bioavailability in rodent models is estimated at <10–15%. It undergoes partial demethylation to naringenin by CYP450 enzymes (notably CYP1A2 and CYP2C9). The aglycone form is moderately lipophilic (LogP ~2.5), allowing passive intestinal absorption, but rapid hepatic clearance limits systemic exposure. Gut microbiota may further metabolize it into smaller phenolic acids (e.g., 4-hydroxyphenylpropionic acid), which may contribute to biological activity.

Preparation & Dosage

No clinically studied dosages exist. Preclinical studies use 10-100 μM in vitro or 10-50 mg/kg in rodents. Commercial products suggest 50-200 mg/day anecdotally without evidence basis. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Isosakuranetin pairs well with (1) Naringenin (50–200 mg), its demethylated parent flavanone, as both converge on NF-κB suppression and TRPM3 modulation but via complementary binding affinities, amplifying anti-inflammatory and analgesic potential; (2) Piperine (5–10 mg), which inhibits hepatic glucuronidation (UGT enzymes) and CYP3A4, thereby significantly improving isosakuranetin's oral bioavailability and extending its plasma half-life; (3) Hesperetin (100–250 mg), a structurally related citrus methoxyflavanone that synergistically enhances antioxidant capacity through parallel activation of the Nrf2/ARE pathway while isosakuranetin modulates PI3K/Akt/mTOR; and (4) Curcumin (200–500 mg, preferably phytosomal form), which provides upstream inhibition of NF-κB via IKKβ blockade, complementing isosakuranetin's downstream MAPK/ERK modulation for a multi-node anti-inflammatory effect. Additionally, Quercetin (100–250 mg) may reduce CYP1A2-mediated demethylation of isosakuranetin, preserving the intact methylated form that is the more potent TRPM3 inhibitor compared to naringenin.

Safety & Interactions

No comprehensive safety data exists for isosakuranetin as a supplement due to lack of human studies. Potential interactions with calcium channel medications or anti-inflammatory drugs are theoretically possible given its TRPM3 inhibition and NF-κB modulation properties. Safety during pregnancy and lactation is unknown and should be avoided without clinical guidance. Individuals taking pain medications or immunosuppressive therapies should consult healthcare providers before use.